• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS EXERA III DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS EXERA III DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-Q190V
Medical Device Problem Code Contamination (1120)
Health Effect - Clinical Codes Abdominal Pain (1685); Bacterial Infection (1735); Nausea (1970); Vomiting (2144); Bacteremia (4846)
Date of Event 04/22/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported there were possible multiple infections of patients after use of an endoscopic retrograde cholangiopancreatography (ercp) scope, an endobronchial ultrasound (ebus) scope, and bronchoscopes that were shared between two sister facilities.At one facility it was reported a patient had a therapeutic ercp procedure done using a duodenovideoscope.Prior to the procedure, the patient experienced symptoms of nausea, vomiting, abdominal pain, abnormal liver function test, and gastric distention.After the procedure, the patient experienced pain in recovery and was kept overnight for observation then discharged the following day.The patient then presented to the emergency department (ed) two days post-procedure with bacteremia, nausea, vomiting, and abdominal pain.Two sets of blood cultures were taken from the patient which tested positive for klebsiella pneumoniae.The patient was admitted for treatment with intravenous (iv) antibiotics.Additionally, the patient underwent an esophagogastroduodenoscopy (egd) procedure to aspirate/suction out 2.5 liters of fluid to help with gastric outlet obstruction.The patient was eventually discharged to a palliative care home.The facility reported that at that time they had not cultured the endoscope or the reprocessor, but the device did pass adenosine triphosphate (atp) testing.The device was quarantined.This report is related to the following linked patient identifiers: (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA III DUODENOVIDEOSCOPE
Common Device Name
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
MDR Report Key19460907
Report Number2429304-2024-0000278
Device Sequence Number6443377
Product Code FDT
UDI-Device Identifier04953170405563
UDI-Public04953170405563
Combination Product (Y/N)N
Initial Reporter StateNC
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Importer
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 06/04/2024
Report Date (Section F) 05/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberTJF-Q190V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date05/07/2024
Device Age2 YR
Event Location Hospital
Date Report to Manufacturer05/07/2024
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date06/04/2024
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age89 YR
Patient SexMale
Patient Weight80 KG
-
-